We Speak Spine Language™

How does Evoke® work?
Measures
the spinal cord’s response
to stimulation
Adjusts
on every pulse to optimize activation
within the patient’s therapeutic window
Maintains
long-term results through ECAP control
in 8 out of 10 patients1
Results of U.S. Evoke Pivotal Study through 12 Months Published in
To request a copy of The Lancet publication
Evoke News
Saluda Medical Highlights Multiple Presentations Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System at NANS Annual Meeting
Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology
See us at NANS 23rd - 26th Jan 2020
Saluda Medical Announces European Commercial Launch of Evoke®, the First and Only ECAP-Controlled, Closed-Loop SCS System for Chronic Pain Relief
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
Saluda Medical Secures Debt Financing From Medtronic
Saluda Medical Announces Clinical Study Results for Evoke® ECAP-Controlled, Closed-Loop SCS System for the Treatment of Chronic Pain
Saluda Medical Announces New 3-Month, 12-Month and 18-Month Data Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System to be Presented at 14th INS World Congress